<DOC>
	<DOCNO>NCT00001120</DOCNO>
	<brief_summary>The purpose study find cancer develop HIV-positive patient . Cancer lead cause death AIDS patient . Common cancer HIV-infected patient include Kaposi 's sarcoma ( KS ) non-Hodgkin 's lymphoma ( NHL ) , cancer immune system . Risk factor include certain chemical , virus , perhaps even anti-HIV drug . Doctors would like find risk factor important relate cancer AIDS patient .</brief_summary>
	<brief_title>A Study Patients With AIDS Syndrome</brief_title>
	<detailed_description>AIDS-associated malignancy represent model system investigation carcinogenesis . There human condition cancer rate magnitude HIV infection . While study investigate pre-cancer marker HIV-infected patient , correlate marker tumor sample . This study contribute understanding oncogenesis HIV-associated malignancy establish collection tumor link pre-cancer serum lymphocyte specimen , well prospective questionnaire data . At study entry , patient receive comprehensive physical exam . Clinic staff interview patient collect data regard medication history ( particularly antiretroviral exposure ) , diet , occupational history , substance abuse , sexual practice . This information use identify behavioral environmental factor contribute oncogenesis . In addition , baseline blood sample analyze HHV-8 EBV level , anti-EBV anti-HHV-8 antibody , CD23 , Th2 cytokine , tumor growth factor , chromosomal translocation associate NHL , potential predictor malignancy . At Month 6 annually thereafter , patient record abstract data vital status , AIDS-defining illness , medication , recent CD4+ T cell HIV RNA level . At Years 1 , 2 , 3 , patient undergo physical exam blood test malignancy surveillance . Any malignancy biopsied analyzed oncogene identification virology . The medical record patient die study review determine cause death rule unreported cancer . No treatment provide study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<mesh_term>Lymphoma , AIDS-Related</mesh_term>
	<criteria>Inclusion Criteria You may eligible trial : Are HIVpositive . Have CD4+ cell count 200 cells/mm3 . Are 18 year age old . Exclusion Criteria You eligible trial : Are available followup least 3 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Prospective Studies</keyword>
	<keyword>Sarcoma , Kaposi</keyword>
	<keyword>Herpesvirus 4 , Human</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Cohort Studies</keyword>
	<keyword>Risk Factors</keyword>
	<keyword>Lymphoma , AIDS-Related</keyword>
	<keyword>Antibodies , Viral</keyword>
	<keyword>Lymphoproliferative Disorders</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Herpesvirus , Kaposi Sarcoma-Associated</keyword>
	<keyword>Translocation ( Genetics )</keyword>
</DOC>